Skip to Content

TEVA 93 293 (Carbidopa and Levodopa 25 mg / 100 mg)

Pill with imprint TEVA 93 293 is Yellow, Round and has been identified as Carbidopa and Levodopa 25 mg / 100 mg. It is supplied by Teva Pharmaceuticals USA.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 93 293

Carbidopa and levodopa 25 mg / 100 mg TEVA 93 293
Carbidopa and levodopa 25 mg / 100 mg TEVA 93 293 Front
Carbidopa and levodopa 25 mg / 100 mg TEVA 93 293 Back
Carbidopa and levodopa 25 mg / 100 mg TEVA 93 293
Carbidopa and levodopa 25 mg / 100 mg TEVA 93 293 Front
Carbidopa and levodopa 25 mg / 100 mg TEVA 93 293 Back
Carbidopa and levodopa 25 mg / 100 mg TEVA 93 293

Carbidopa and Levodopa

Imprint:
TEVA 93 293
Strength:
25 mg / 100 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide